SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993;15: 11032.
  • 2
    Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 1997;216: 2843.
  • 3
    Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk JAMA. 1997;278: 140711.
  • 4
    Yong LC, Brown CC, Schatzkin A, et al. Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987–1989. Am J Epidemiol 1996;143: 98595.
  • 5
    Ursin G, Longnecker MP, Haile RW, et al. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995;6: 13741.
  • 6
    Ballard-Barbash R. Anthropometry and breast cancer. Body size—a moving target. Cancer 1994;74: 1090100.
  • 7
    Ziegler RG. Anthropometry and breast cancer. J Nutr 1997;127: 924S928S.
  • 8
    Stoll BA. Obesity and breast cancer. Int J Obes Relat Metab Disord 1996;20: 38992.
  • 9
    Ballard-Barbash R, Swanson CA. Body weight: estimation of risk for breast and endometrial cancers. Am J Clin Nutr 1996;63: 437S41S.
  • 10
    Mohle-Boetani JC, Grosser S, Whittemore AS, et al. Body size, reproductive factors, and breast cancer survival. Prevent Med 1988;17: 63442.
  • 11
    Reeves MJ, Newcomb PA, Remington PL, et al. Body mass and breast cancer. Relationship between method of detection and stage of disease. Cancer. 1996;77: 3017.
  • 12
    den Tonkelaar I, de Waard F, Seidell JC, et al. Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project. Breast Cancer Res Treat 1995;34: 12937.
  • 13
    Ingram D, Nottage E, Ng S, et al. Obesity and breast disease. The role of the female sex hormones. Cancer 1989;64: 104953.
  • 14
    Zumoff B, Dasgupta I. Relationship between body weight and the incidence of positive axillary nodes at mastectomy for breast cancer. J Surg Oncol 1983;22: 21720.
  • 15
    Greenberg ER, Vessey MP, McPherson K, et al. Body size and survival in premenopausal breast cancer. Br J Cancer 1985;51: 6917.
  • 16
    Jones BA, Kasi SV, Curnen MG, et al. Severe obesity as an explanatory factor for the black/white difference in stage at diagnosis of breast cancer. Am J Epidemiol 1997;146: 394404.
  • 17
    Weiss SE, Tartter PI, Ahmed S, et al. Ethnic differences in risk and prognostic factors for breast cancer. Cancer 1995;76: 26874.
  • 18
    Hall HI, Coates RJ, Uhler RJ, et al. Stage of breast cancer in relation to body mass index and bra cup size. Int J Cancer 1999;82: 237.
  • 19
    Boyd NF, Campbell JE, Germanson T, et al. Body weight and prognosis in breast cancer. J Natl Cancer Inst 1981;67: 7859.
  • 20
    Moritz DJ, Satariano WA. Factors predicting stage of breast cancer at diagnosis in middle aged and elderly women: the role of living arrangements. J Clin Epidemiol 1993;46: 44354.
  • 21
    Howson CP, Kinne D, Wynder EL. Body weight, serum cholesterol, and stage of primary breast cancer. Cancer 1986;58: 237281.
  • 22
    Donegan WL, Hartz AJ, Rimm AA. The association of body weight with recurrent cancer of the breast. Cancer 1978;41: 15904.
  • 23
    Daniell HW. Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer 1988;62: 42935.
  • 24
    Verreault R, Brisson J, Deschenes L, et al. Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors. Am J Epidemiol 1989;129: 2608.
  • 25
    Senie RT, Rosen PP, Rhodes P, et al. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Intern Med 1992;116: 2632.
  • 26
    Bastarrachea J, Hortobagyi GN, Smith TL, et al. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 1994;120: 1825.
  • 27
    London SJ, Colditz GA, Stampfer MJ, et al. Prospective study of relative weight, height, and risk of breast cancer. JAMA 1989;262: 28538.
  • 28
    Hoe AL, Mullee MA, Royle GT, et al. Breast size and prognosis in early breast cancer. Ann R Coll Surg Engl 1993;75: 1822.
  • 29
    Schapira DV, Kumar NB, Lyman GH, et al. Obesity and body fat distribution and breast cancer prognosis. Cancer 1991;67: 5238.
  • 30
    Ingram DM, Huang HY, Catchpole BN, et al. Do big breasts disadvantage women with breast cancer? Aust NZ J Surg 1989;59: 1157.
  • 31
    NIH. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Executive summary. Bethesda, MD: NIH, 1998. 726.
  • 32
    Najiar MF, Rowland M. Anthropometric reference data and prevalence of overweight, United States, 1976–80. Vital Health Stat 1987;11(238).
  • 33
    BeahrsOH, HensonDE, HutterRV, et al., eds. American Joint Committee on Cancer. Manual for staging of cancer, 4th ed. Philadelphia: J.B. Lippincott Company, 1992. 14954.
  • 34
    Rosen PP. Rosen's breast pathology. Philadelphia: Lippincott-Raven Publishers, 1997.
  • 35
    Spiessl B, Hermanek P, Scheibe O, et al, eds. Internation Union Against Cancer. TNM Atlas. Illustrated guide to the TNM/pTNM-classification of malignant tumours, 2nd ed. Berlin: Springer-Verlag, 1982. 6777.
  • 36
    Michalski TA, Nattinger AB. The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries. Cancer 1997;79: 3149.
  • 37
    Burns RB, McCarthy EP, Freund KM, et al. Black women receive less mammography even with similar use of primary care. Ann Intern Med 1996;125: 17382.
  • 38
    McCarthy BD, Yood MU, MacWilliam CH, et al. Screening mammography use: the importance of a population perspective. Am J Prev Med 1996;12: 915.
  • 39
    Simon MS, Severson RK. Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology. Am J Obstet Gynecol 1997;176: 2339.
  • 40
    Gordon NH. Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol 1995;142: 796803.
  • 41
    Breen N, Figueroa JB. Stage of breast and cervical cancer diagnosis in disadvantaged neighborhoods: a prevention policy perspective. Am J Prev Med. 1996;12: 31926.
  • 42
    Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;82: 70310.
  • 43
    Schapira DV, Kumar NB, Lyman GH. Obesity, body fat distribution, and sex hormones in breast cancer patients. Cancer 1991;67: 22158.
  • 44
    Kuller LH. Eating fat or being fat and risk of cardiovascular disease and cancer among women. Ann Epidemiol 1994;4: 11927.
  • 45
    Hulka BS, Liu ET, Lininger RA. Steroid hormones and risk of breast cancer. Cancer 1994;74: 111124.
  • 46
    Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15: 4865.
  • 47
    Bulun SE, Mahendroo MS, Simpson ER. Aromatase gene expression in adipose tissue: relationship to breast cancer. J Steroid Biochem Mol Biol 1994;49: 31926.
  • 48
    Bulun SE, Price TM, Aitken J, et al. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 1993;77: 16228.
  • 49
    O'Neill JS, Elton RA, Miller WR. Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. BMJ (Clin Res Ed) 1988;296: 7413.
  • 50
    Hankinson SE, Willett WC, Manson JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995;87: 1297302.
  • 51
    Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem 1990;27: 53241.
  • 52
    Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24: 2943.